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Areca (betel) chewing is associated with the high incidence of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis
(OSF) in Asians. Heme oxygenase-1 (HO-1), encoding an oxidative response protein, plays protective roles in cells. A (GT)n
microsatellite repeat in HO-1 promoter shows polymorphisms and modulates the level of gene transcription. We examined
allelotypic frequencies of (GT)n repeats in 83 controls, 147 OSCC and 71 OSF. All subjects were male areca chewers. Logistic
regression was used to adjust the age confounding for odds ratio (OR). (GT)n repeat polymorphism was classified into short (S),
medium (M) and long (L) alleles. The adjusted OR in OSCC subjects carrying L allelotype relative to S allelotype was 1.75. Buccal
squamous cell carcinoma (BSCC) is the most common OSCC subset in areca chewers. L allelotype implied the risk of BSCC with
adjusted OR of 2.05, whereas M allelotype appeared protective for non-BSCC with adjusted OR of 0.49. Our findings indicated that
longer (GT)n repeat allele in HO-1 promoter is associated with the risks of areca-related OSCC, while the shorter (GT)n repeat allele
may have protective effects for OSCC.
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Heme oxygenase (HO) is a rate-limiting enzyme that degrades
heme to produce biliverdin, CO and free iron. It was also named as
heat shock protein 32 (Maines, 1988). Three HO isoforms have
been identified in human. Heme oxygenase-1 is an inducible
isoform of HO in response to stresses, including heat shock, UV
irradiation, hydrogen peroxide, heavy metals, glutathione deletion,
hypoxia and NO (Maines, 1988; Shibahara, 1988; Keyse and
Tyrrell, 1989; Oguro et al, 1996; Doi et al, 1999; Motterlini et al,
2000). The induction of HO-1 represents a cytoprotective defence
mechanism against oxidative insults. Like other heat shock
proteins, high expression of HO-1 was found in malignant tumours
(Maines and Abrahamsson, 1996; Goodman et al, 1997). Admin-
istration of the HO inhibitor suppressed the growth of tumour
cells, which suggests a vital role of HO-1 in tumour growth (Doi
et al, 1999; Fang et al, 2003). In addition, HO inhibitor also
induced the apoptosis of tumour cells, suggesting the roles of HO-1
in maintaining cancer cell survival (Fang et al, 2003). Reports have
addressed that HO-1 plays important roles in angiogenesis of
prostate cancers (Sunamura et al, 2003).
Oral squamous cell carcinoma (OSCC) is the third most
common malignancy in developing countries and the sixth
worldwide. It accounts for up to 50% of malignant tumours in
some South Asia countries due to the popularity of areca (betel)-
chewing habit. Around 200–600 million Asians chew areca (Liu
et al, 1996; Jeng et al, 2001; Lin et al, 2002; Lo et al, 2003; Sharma,
2003). OSCC is also a prevalent disease in Taiwan as the fourth
leading malignancy in male population (Lin et al, 2000, 2002; Jeng
et al, 2001; Kao et al, 2002; Lo et al, 2003; Wong et al, 2003). Areca
was recently approved a carcinogen that produces oxidative stress
and genotoxicity (Liu et al, 1996; Jeng et al, 2001; Bagchi et al,
2002; Sharma, 2003). Since buccal mucosa is the primary site for
the insults of areca, buccal squamous cell carcinoma (BSCC) is the
most common subset of OSCC accounting for more than 60% of
OSCC in South Asians (Lin et al, 2000; Kao et al, 2002; Lo et al,
2003; Wong et al, 2003). It was found that a subset of OSCC, which
occurred on tongue with higher HO-1 expression, contained
significantly more differentiated samples and cases without lymph
node involvement, which implicated that HO-1 expression could be
disadvantageous for OSCC progression (Yanagawa et al, 2004).
Areca chewing is also exclusively associated with the occurrence
of oral submucous fibrosis (OSF), which is a precancerous
condition exhibiting disturbances in homeostasis of fibrous tissue
and altered epithelial components (Chiu et al, 2001, 2002; Yang
et al, 2001; Ko et al, 2003; Liu et al, 2004; Shin et al, 2004). Oral
submucous fibrosis was originally called idiopathic scleroderma of
the mouth. This disease is characterised by mucosal rigidity due to
the fibro-elastic transformation of the juxta-epithelial layer. A
subepithelial inflammatory reaction and epithelial atrophy is
frequently accompanied with the fibrous changes of the lamina
propria (Shin et al, 2004). It is interesting that OSF seems to be a
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ypublic health issue in many parts of the world, including the UK
and South Africa, due to the spreading of areca chewing (Canniff
et al, 1986; Yang et al, 2001; Shin et al, 2004). However, the genetic
susceptibility or disease nature of OSF is still largely undefined.
(GT)n repeats were identified in the proximal region of HO-1
promoter. Reports indicated that these microsatellites are highly
polymorphic, and longer (GT)n repeat exhibits lower HO-1
transcriptional activity (Yamada et al, 2000; Chen et al, 2002,
2004; Kaneda et al, 2002). Subjects carrying longer (GT)n repeats
are associated with the higher susceptibility of cardiovascular or
chronic obstructive pulmonary diseases (Yamada et al, 2000; Chen
et al, 2002, 2004; Kaneda et al, 2002). Oxidative stress is associated
with the pathogenesis of cancers (Xie and Huang, 2003). However,
the association between HO-1 promoter polymorphism and cancer
risk has not been established. Although HO-1 expression might be
related to the biological behaviour of OSCC (Yanagawa et al, 2004),
the involvement of functional HO-1 polymorphisms in the risk of
oral diseases has not been defined. We hypothesised that higher
(GT)n repeats may be associated with the risk of OSCC and OSF.
We showed that (GT)n repeats polymorphism in HO-1 was a risk
factor for OSCC. In addition, polymorphic profile differences
seemed to differentially predict BSCC and non-BSCC subsets.
MATERIALS AND METHODS
Samples
A total of 147 primary OSCC without previous treatment and 71
OSF cases were obtained from the Oral and Maxillofacial Surgery
Department of the Taipei Mackay Memorial Hospital. In all, 83
control subjects were selected from people who came for physical
checkup, and had no neoplastic minor oral operations or
maxillofacial trauma. Those with autoimmune disorders, blood
diseases and previous malignancies were excluded from the
control group. The site, stage and TNM classification of OSCC
subjects are described in Table 1. This study was approved by an
ethics reviewing committee. Blood was drawn from the subjects. A
leukocyte cell pellet was obtained from the buffy coat by
centrifugating the whole blood. DNA was isolated by Blood Mini
Kit (Qiagen, Valencia, CA, USA).
Heme oxygenase-1 genotyping
(GT)n repeat polymorphism in the HO-1 promoter was determined
by PCR-based genotyping. The primers used to generate HO-1
amplicons of 98–142bp were sense: 50-AGAGCCTGCAGCTTCT
CAGA-30 and antisense: 50-ACAAAGTCTGGCCATAGGAC-30
(Kaneda et al, 2002). The 50 site of the sense primer was labelled
with FAM fluorescence dye. The amplification reaction mixture
(15ml) contained 20ng genomic DNA, 0.2mM of each dNTP, 0.5mM
of each primer, 0.5U Prozyme DNA polymerase (Protech
Enterprise, Taipei, Taiwan) and 1  PCR buffer. The PCR reaction
was carried out in three steps: firstly, 2min at 941C; then, 30 cycles
of 30s at 941C, 30s at 561C and 30s at 721C; lastly, 5min at 721C.
The amplicons were denatured for 5min at 1001C, and mixed with
formamide-containing stop buffer, and then subjected to electro-
phoresis on 4% polyacrylamide gel containing 8 M urea in an ABI
Prism 377-18 DNA sequencer (Applied Biosystem, Foster City, CA,
USA). The fluorescence was detected automatically by Genescan
672 software (Applied Biosystem). At least two independent
experiments were performed on each sample to assure the
reliability of the analyses.
DNA sequencing
Selected amplicons with various allelic sizes were cloned into
pGEM-T vector (Promega, Madison, MI, USA). Five clones from
each allele were sequenced using a 377-18 DNA sequencer (Applied
Biosystem) and vector primers were used to confirm the number
of GT repeats revealed by genotyping.
Statistical analysis
Associations between the HO-1 polymorphisms and risk of disease
genesis were estimated by odds ratio (OR) and associated 95%
confidence interval (CI), which were calculated by logistic
regression models using SPSS version 8.0 (SPSS Inc., Chicago,
IL, USA). Differences between the variants were considered
significant when Po0.05.
RESULTS
All subjects were male areca chewers. The ages (mean7s.d.) of
OSCC, OSF and control subjects were 51.379.8, 39.0710.8 and
47.1710.0, respectively. In all, 61% (90 cases) of the OSCC subjects
were BSCC, 37% (54 cases) of the OSCC patients presented with
lymph node metastasis (LNM) and 63% (97 cases) of patients had
late stage lesions (Table 1).
The genotyping of (GT)n microsatellite polymorphism in HO-1
promoter region was carried out by Genescan system. It
distinguished (GT)n repeats on the basis of differential mobility
of amplicons with different sizes. The repeat numbers were derived
from the amplicon size and the sequencing reading in cloned
alleles. The allelotypic distribution of HO-1 polymorphism of
control, OSCC and OSF is shown in Figure 1. In controls, the GT
repeat numbers ranged from 19 to 37, and the most common
alleles were (GT)23 and (GT)30, which were consistent with
previous Taiwanese studies (Chen et al, 2002, 2004). The alleles
were classified into three subgroups: the shorter component (p25
repeats) was designated as class ‘S’, the medium component (26–
30 repeats) was designated as class ‘M’ and the longer component
(X31 repeats) was designated as class ‘L’. Table 2 describes the
genotypes from Genescan analysis. Table 3 describes that the
frequency of L allelotype was significantly increased in OSCC
subjects in relation to control subjects, with an age-adjusted OR of
1.75. The frequency of L allelotype was also significantly increased
in OSF subjects relative to control subjects before adjusting.
However, after adjusting for age, OR remarkably declined to an
insignificant level (Table 3).
Table 1 Clinical parameters of OSCC subjects
Site
Buccal mucosa 90
Tongue 35
Gingiva 14
Palate 5
Floor of mouth 3
Stage and TNM
a
Stage I 15
Stage II 35
Stage III 20
T1N1M0 2
T2N1M0 5
T3N0M0 11
T3N1M0 2
Stage IV 77
T2N2M0 3
T3N2M0 3
T4N0M0 32
T4N1M0 24
T4N2M0 8
T4N3M0 7
aAccording to UICC classification system.
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LNM and stage, was performed to elucidate the relationship
between HO-1 polymorphism and OSCC. The allelotypic distribu-
tions of HO-1 polymorphism in control, BSCC and non-BSCC
subjects are shown in Figure 2. A significantly higher difference in
frequencies of L allelotype was noted in BSCC subjects compared
with control subjects (Table 4). Interestingly, the frequency of M
allelotype in non-BSCC subjects was significantly reduced in
relation to control subjects (Table 4). Analyses revealed no
statistically significant difference in the HO-1 polymorphism in
OSCC subjects that exhibited different LNM and clinical stage
(detailed analysis not shown).
DISCUSSION
In this case–control study, we have identified a significant
association between GT repeat length in HO-1 promoter and the
risks of OSCC occurring in male areca chewers, particular for the
BSCC subset. Increases in risk were observed for subjects with a
GT repeat X31, which suggested that shorter GT repeat alleles
could have a protective effect on OSCC. The results also supported
previous findings suggesting better protection against disease
formations in subjects carrying shorter HO-1 GT repeats (Yamada
et al, 2000; Chen et al, 2002, 2004; Kaneda et al, 2002). Since HO-1
is critical for converting heme to bilirubin, CO and iron, we have
examined the correlation between HO-1 polymorphisms and
serum bilirubin to support the notion that subjects with longer
GT repeat might have higher serum bilirubin. Although we
observed a trend that subjects carrying L allelotype have a higher
serum bilirubin level, the increase did not reach a statistical
significance (detailed analysis not shown). It is plausible that the
induction of HO-1 only occurs in local tissue and may not
necessarily stand out from measuring circulating bilirubin level,
since serum bilirubin level is affected by multiple systemic factors
including liver function. Male areca chewers with L allelotype have
1.75 or 2.05 times higher risk for OSCC or BSCC, respectively,
compared to those carrying S allelotype. To our knowledge, this is
the first study investigating the roles of HO-1 promoter
polymorphism on OSCC risks.
Oral submucous fibrosis is a unique disease characterised by the
unbalance between synthesis and degradation of extracellular
matrix (Chiu et al, 2002), and occurred exclusively in areca
chewers (Chiu et al, 2001, 2002; Ko et al, 2003; Liu et al, 2004). It is
considered as an inflammatory reaction in response to areca
ingredients or physical irritation, while the covering epithelium
may exhibit precancerous changes undertaking malignant trans-
formation (Ko et al, 2003). The fact that areca disrupts cytokine
production and molecules for organising the extracellular matrix
seems to play important roles in OSF pathogenesis. Studies have
demonstrated that the functional polymorphism of genes on
immune reaction, such as MICA (Liu et al, 2004), CTLA4 (Shin
et al, 2004), collagen-related genes (Chiu et al, 2002) and cytokines
(Chiu et al, 2001), were associated with the risk of OSF. The OSF
patients usually came for medical helps for resolution of oral
symptoms early in their lives. Thereby, the mean age of OSF
subjects is around 10 years younger than control or OSCC subjects
in our study cohort. In this study, the risk of L allelotype in HO-1
promoter for OSF became not significant after adjusting for age. It
was speculated that the protection driven by HO-1 is not sufficient
for counteracting the oxidative stress elicited by areca, which
might cause the pathogenesis of OSF (Liu et al, 1996). Age-related
confounding factors or genetic events contributive to OSF genesis
deserve further dissection.
We identified that the longer GT repeat length was highly
associated BSCC. In contrast, medium GT length was inversely
associated with non-BSCC. The data suggest that HO-1 poly-
morphism might have a profound effect on the risk of getting
carcinomas at different oral locations. Buccal squamous cell
carcinoma accounts for more than 60% of the total areca-
associated OSCC, but it is extremely rare in the West (Lin et al,
2002, 2004; Lo et al, 2003). Previous studies from us have specified
the great molecular discrepancies between BSCC and non-BSCC
(Lin et al, 2000; Kao et al, 2002). Interestingly, the frequency of a
functional genotype in CCND1 and MMP-1 was also contradictory
between BSCC and non-BSCC (Wong et al, 2003; Lin et al, 2004).
In the present study, we further proposed the distinctive HO-1
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Figure 1 Allelotypic distribution of HO-1 (GT)n repeat polymorphisms in control, OSCC and OSF subjects.
Table 2 HO-1 genotype in subjects
Genotype
Control
(n¼83)
OSCC
(n¼147)
OSF
(n¼71)
BSCC
(n¼90)
Non-BSCC
(n¼57)
SS 17 29 7 14 15
SM 29 30 23 17 14
SL 11 34 20 19 15
MM 13 20 8 16 4
ML 12 27 8 20 6
LL 1 7 5 4 3
Table 3 Association between HO-1 allelotype and risks of OSCC and
OSF subjects
Control OSCC OSF
nn P OR 95% CI nPOR 95% CI
S 74 122 1.00 57 1.00
M 67 97 0.581 0.88 0.57–1.34 47 0.796 0.91 0.55–1.51
L 25 75 0.030 1.81 1.06–3.10 38 0.035 1.95 1.06–3.59
L
a 0.045 1.75 1.01–3.03 0.160 1.61 0.83–3.13
aAdjusted for age.
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Evidences accumulated might suggest that BSCC, which is
quite prevalent in Asians, exhibits distinctive pathways for
tumorigenesis.
Heme oxygenase-1 expression has been reported to enhance
growth against apoptosis and induce angiogenesis through
increase in angiogenic factor and VEGF in endothelial cells and
cancer cells (Deramaudt et al, 1998; Doi et al, 1999; Kushida et al,
2002; Malaguarnera et al, 2002, 2003; Fang et al, 2003; Sunamura
et al, 2003). Such phenotypes are advantageous for tumour
progression and survival. However, a recent paper, denoting the
lower HO-1 expression in head and neck carcinomas with LNM,
has argued that the increase of HO-1 expression as a cause or a
consequence of carcinogenesis (Yanagawa et al, 2004). Preliminary
evidences from us indicated that HO-1 promoter polymorphism
had no impact on tumour progression, reflecting by metastasis or
advanced clinical stage. It might exclude the role of HO-1
polymorphism as a risk marker of tumour dissemination, although
such polymorphism could affect transcription. This could be
partially interpreted by the multiple factors involving in the
tumour progression, which mask the crucial role of HO-1
genotype. Advanced tumours exhibited tremendous potentials to
survive in a stress microenvironment, with hypoxia and free
radical overproduction (Xie and Huang, 2003). Thereby, the
extensive stress on advanced tumours may have secondary or
selective effects on HO-1 expression. Additional genotypic surveys
using more samples and confounders, together with HO-1
expression profile, are required to further insight the functional
importance of HO-1 in cancer progression.
Overall, our clues indicated that longer GT repeat allele in HO-1
promoter is associated with the risks of areca-associated oral
carcinogenesis. The findings also suggest that shorter GT repeat
allele in HO-1 promoter may have protective effects for OSCC in
our study cohort.
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